Up to 1,000 additional blood platelet donors are needed in the coming year to meet demand, as "there is no substitute for platelets".
Background Up to half of patients with infective endocarditis (IE) require cardiac surgery. Although anaemia is common, its precise prevalence, transfusion practices and impact on outcomes in ...
With people’s busy schedules, giving blood “isn’t necessarily top of mind,” an officials says, but it’s needed more than ever ...
Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...
The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell ...
Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...
Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...
A case report described a woman with endometrial cancer in India with an extremely rare blood group type, complicating blood ...
The use of cryopreserved platelets is associated with higher perioperative blood loss, higher transfusion use, and longer ICU ...
AdventHealth Medical Group has added Dukens Labaze, MD, and Ahrash Khajaei, DO. Dr. LaBaze is an orthopedic surgeon specializing in adult joint reconstruction, including hip and knee replacements, ...
The North Texas Region of the Red Cross operates two fixed donation sites in the area: the Irving Blood and Platelet Donation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback